Gingko Bioworks, valued at $15B, begins trading today: Here’s how their business works

Gingko Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the…

How Colossal sold investors on a quest to resurrect a woolly mammoth

There are a growing number of companies interested in CRISPR’s potential to upend medicine. It’s probably…

DotCom Therapy raises $13M to provide therapy for kids, in and out of school

DotCom Therapy, a pediatric teletherapy company, just closed a $13 million Series A round. It’s far…

Breakout ‘CRISPR platform’ company Mammoth Biosciences is officially a unicorn

The CRISPR-based biotech startup Mammoth Biosciences is officially a unicorn, the company says.  The billion-dollar valuation…

Emulate Inc closes $82M Series E to fund expansion of “*****-on-a-chip” products

Emulate Inc., a biotech company focused on developing “*****-on-a-chip” technology, closed an $82 million Series E…

Digital therapy program for fibromyalgia receives FDA breakthrough device designation

Swing Therapeutics, a digital therapeutics startup, has received an FDA breakthrough device designation for their 12…

GSK and R/GA Ventures are launching a health studio for startups

GSK Next, the innovation arm of GlaxoSmithKlein, is launching a new mentorship and business development program.…

Aduhelm approval sparks HHS watchdog review of FDA’s accelerated approval pathway

The Department of Health and Human Services (HHS) Office of the Inspector General will review the…

As the delta variant surges, a nonprofit app lets hospital patients call home for free on any device 

COVID Tech Connect, a nonprofit created during the first wave of the coronavirus pandemic in the…

Rani Therapeutics’ $73M IPO will fund upcoming clinical trials

Rani Therapeutics, a San Jose-based company developing a pill to replace medical injections, went public on…